185 related articles for article (PubMed ID: 33239429)
1. EMT Transcription Factor ZEB1 Represses the Mutagenic POLθ-Mediated End-Joining Pathway in Breast Cancers.
Prodhomme MK; Pommier RM; Franchet C; Fauvet F; Bergoglio V; Brousset P; Morel AP; Brunac AC; Devouassoux-Shisheboran M; Petrilli V; Moyret-Lalle C; Hoffmann JS; Puisieux A; Tissier A
Cancer Res; 2021 Mar; 81(6):1595-1606. PubMed ID: 33239429
[TBL] [Abstract][Full Text] [Related]
2. Regulating Polθ in Breast Cancer.
Carvajal-Maldonado D; Wood RD
Cancer Res; 2021 Mar; 81(6):1441-1442. PubMed ID: 33723002
[TBL] [Abstract][Full Text] [Related]
3. Opposite Roles for ZEB1 and TMEJ in the Regulation of Breast Cancer Genome Stability.
Prodhomme MK; Péricart S; Pommier RM; Morel AP; Brunac AC; Franchet C; Moyret-Lalle C; Brousset P; Puisieux A; Hoffmann JS; Tissier A
Front Cell Dev Biol; 2021; 9():727429. PubMed ID: 34458275
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide binding of transcription factor ZEB1 in triple-negative breast cancer cells.
Maturi V; Enroth S; Heldin CH; Moustakas A
J Cell Physiol; 2018 Oct; 233(10):7113-7127. PubMed ID: 29744893
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic functions of the EMT-related transcription factor ZEB1 in breast cancer.
Wu HT; Zhong HT; Li GW; Shen JX; Ye QQ; Zhang ML; Liu J
J Transl Med; 2020 Feb; 18(1):51. PubMed ID: 32014049
[TBL] [Abstract][Full Text] [Related]
6. ZEB1 induces ROS generation through directly promoting MCT4 transcription to facilitate breast cancer.
Han X; Long Y; Duan X; Liu Z; Hu X; Zhou J; Li N; Wang Y; Qin J
Exp Cell Res; 2022 Mar; 412(2):113044. PubMed ID: 35093305
[TBL] [Abstract][Full Text] [Related]
7. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
8. Ets1 and ESE1 reciprocally regulate expression of ZEB1/ZEB2, dependent on ERK1/2 activity, in breast cancer cells.
Sinh ND; Endo K; Miyazawa K; Saitoh M
Cancer Sci; 2017 May; 108(5):952-960. PubMed ID: 28247944
[TBL] [Abstract][Full Text] [Related]
9. BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells.
Yu JM; Sun W; Hua F; Xie J; Lin H; Zhou DD; Hu ZW
Cancer Lett; 2015 Sep; 365(2):190-200. PubMed ID: 26049022
[TBL] [Abstract][Full Text] [Related]
10. Zeb1-mediated autophagy enhances resistance of breast cancer cells to genotoxic drugs.
Fedorova O; Daks A; Parfenyev S; Shuvalov O; Netsvetay S; Vasileva J; Gudovich A; Golotin V; Semenov O; Petukhov A; Baiduik E; Berdigaliyev N; Tulchinsky EM; Barlev NA
Biochem Biophys Res Commun; 2022 Jan; 589():29-34. PubMed ID: 34883287
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide cooperation of EMT transcription factor ZEB1 with YAP and AP-1 in breast cancer.
Feldker N; Ferrazzi F; Schuhwerk H; Widholz SA; Guenther K; Frisch I; Jakob K; Kleemann J; Riegel D; Bönisch U; Lukassen S; Eccles RL; Schmidl C; Stemmler MP; Brabletz T; Brabletz S
EMBO J; 2020 Sep; 39(17):e103209. PubMed ID: 32692442
[TBL] [Abstract][Full Text] [Related]
12. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
[TBL] [Abstract][Full Text] [Related]
13. The transcriptional factor ZEB1 represses Syndecan 1 expression in prostate cancer.
Farfán N; Ocarez N; Castellón EA; Mejía N; de Herreros AG; Contreras HR
Sci Rep; 2018 Jul; 8(1):11467. PubMed ID: 30065348
[TBL] [Abstract][Full Text] [Related]
14. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
Kong X; Ding X; Li X; Gao S; Yang Q
Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
[TBL] [Abstract][Full Text] [Related]
15. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells.
Graham TR; Yacoub R; Taliaferro-Smith L; Osunkoya AO; Odero-Marah VA; Liu T; Kimbro KS; Sharma D; O'Regan RM
Breast Cancer Res Treat; 2010 Aug; 123(1):139-47. PubMed ID: 19921427
[TBL] [Abstract][Full Text] [Related]
17. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
[TBL] [Abstract][Full Text] [Related]
18. Radiation exposure triggers the progression of triple negative breast cancer via stabilizing ZEB1.
Lin Y; Bai X; Zhou W; He Y; Wu Y; Wang X
Biomed Pharmacother; 2018 Nov; 107():1624-1630. PubMed ID: 30257380
[TBL] [Abstract][Full Text] [Related]
19. ZEB1 directly inhibits GPX4 transcription contributing to ROS accumulation in breast cancer cells.
Han X; Duan X; Liu Z; Long Y; Liu C; Zhou J; Li N; Qin J; Wang Y
Breast Cancer Res Treat; 2021 Jul; 188(2):329-342. PubMed ID: 34169392
[TBL] [Abstract][Full Text] [Related]
20. The EMT-activator ZEB1 induces bone metastasis associated genes including BMP-inhibitors.
Mock K; Preca BT; Brummer T; Brabletz S; Stemmler MP; Brabletz T
Oncotarget; 2015 Jun; 6(16):14399-412. PubMed ID: 25973542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
